ILESX
Price
$10.60
Change
-$0.00 (-0.00%)
Updated
Jul 16 closing price
Net Assets
309.28K
VIGAX
Price
$230.53
Change
+$1.26 (+0.55%)
Updated
Jul 17 closing price
Net Assets
311.95B
Interact to see
Advertisement

ILESX vs VIGAX

Header iconILESX vs VIGAX Comparison
Open Charts ILESX vs VIGAXBanner chart's image
FI Instl Grp US Lrg Cp Eq Env & Scl Val
Price$10.60
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets309.28K
Vanguard Growth Index Admiral
Price$230.53
Change+$1.26 (+0.55%)
VolumeN/A
Net Assets311.95B
ILESX vs VIGAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ILESX vs. VIGAX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ILESX is a StrongBuy and VIGAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGAX has more cash in the bank: 312B vs. ILESX (309K). ILESX pays higher dividends than VIGAX: ILESX (0.76) vs VIGAX (0.45). ILESX was incepted earlier than VIGAX: ILESX (5 years) vs VIGAX (25 years). ILESX (66.83) is less costly to investors than VIGAX (0.05). ILESX is a more actively managed with annual turnover of: 19.00 vs. VIGAX (11.00). ILESX has a lower initial minimum investment than VIGAX: ILESX (0) vs VIGAX (3000). VIGAX annual gain was more profitable for investors over the last year : 18.35 vs. ILESX (-38.93). VIGAX return over 5 years is better than : 111.02 vs. ILESX (10.06).
ILESXVIGAXILESX / VIGAX
Total Expense Ratio0.470.05940%
Annual Report Gross Expense Ratio66.830.05133,660%
Fund Existence5 years25 years-
Gain YTD-40.1828.546-470%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets309K312B0%
Annual Yield % from dividends0.760.45171%
Returns for 1 year-38.9318.35-212%
Returns for 3 years-2.7294.27-3%
Returns for 5 years10.06111.029%
Returns for 10 yearsN/A300.74-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TROW106.413.36
+3.26%
T Rowe Price Group
PTGX56.44-0.20
-0.35%
Protagonist Therapeutics
TMCI5.79-0.06
-1.03%
Treace Medical Concepts
RAPT10.23-0.29
-2.76%
RAPT Therapeutics Inc
KAPA1.02-0.07
-6.42%
Kairos Pharma Ltd.